Search
for
Sort by
Research 541–570 of 1000+
- Androgens inhibit phagocytosis by macrophages via the androgen receptor in vitro
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- The Comparative Effects Between Long‐Term and Short‐Term Treatment of Finasteride on Anxiety‐Like and Depression‐Like Behaviors in Early Senescent Male Rats
- (291) The Effect of Administration and Discontinuation of Finasteride in Male Rats
- Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Treatment of Frontal Fibrosing Alopecia
- [A new treatment for androgenetic alopecia : platelet-rich plasma injections].
- Post-finasteride syndrome: our current knowledge
- Dutasteride/finasteride
- Adverse events with finasteride or dutasteride: FAERS
- Current and Future Medical Treatment of Androgenetic Alopecia
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- 054 Post Finasteride Syndrome: Guess Who-Demographics from FDA Database
- Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint
- Urinary symptoms in patients with androgenetic alopecia
- [Androgenetic alopecia].
- Androgenetic alopecia, hirsutism and hypertrichosis
- Physiology and Medical Treatments for Alopecia
- Effects of finasteride on the morphology of polycystic ovaries
- New Drugs: Dutasteride
- Pathogenesis of androgenetic alopecia
- Serenoa repens: Does it have any role in the management of androgenetic alopecia?
- Hormonal prevention of prostate cancer
- Olanzapine counteracts stress-induced anxiety-like behavior in rats
- Trace elements content and hormonal profiles in women with androgenetic alopecia
- HAIR LOSS AND REGENERATION PERFORMED ON ANIMAL MODELS
- Aphalangia possibly linked to unintended use of finasteride during early pregnancy
- The pregnant urologist
- Saw palmetto and finasteride in the treatment of category-iii prostatitis/chronic pelvic pain syndrome